We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SILK
2126
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$8.27M ﹤0.01%
197,436
+184,819
+1,465% +$7.1M
ITRI icon
2127
Itron
ITRI
$4.45B
$8.24M ﹤0.01%
124,329
+14,235
+13% +$907K
NXE icon
2128
NexGen Energy
NXE
$6.37B
$8.23M ﹤0.01%
6,383,307
+60,974
+1% +$77.9K
WSM icon
2129
Williams-Sonoma
WSM
$29.2B
$8.23M ﹤0.01%
200,710
-12,998
-6% -$442K
HMSY
2130
DELISTED
HMS Holdings Corp.
HMSY
$8.23M ﹤0.01%
254,008
-531,198
-68% -$15.4M
TRUE
2131
DELISTED
TrueCar
TRUE
$8.22M ﹤0.01%
3,187,800
-2,066,928
-39% -$5.3M
USFD icon
2132
US Foods
USFD
$21.7B
$8.21M ﹤0.01%
416,516
+216,716
+108% +$4.14M
PBE icon
2133
Invesco Biotechnology & Genome ETF
PBE
$283M
$8.21M ﹤0.01%
140,886
+5,846
+4% +$318K
MCA
2134
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$8.21M ﹤0.01%
591,703
-1,737
-0.3% -$23.3K
CROX icon
2135
Crocs
CROX
$6.65B
$8.18M ﹤0.01%
222,157
+11,267
+5% +$298K
GGN
2136
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$773M
$8.17M ﹤0.01%
2,375,728
-63,722
-3% -$211K
UBSI icon
2137
United Bankshares
UBSI
$6.75B
$8.16M ﹤0.01%
295,156
-29,027
-9% -$779K
BRKL
2138
DELISTED
Brookline Bancorp
BRKL
$8.15M ﹤0.01%
808,081
-20,018
-2% -$200K
IPGP icon
2139
IPG Photonics
IPGP
$3.77B
$8.14M ﹤0.01%
50,764
-6,120
-11% -$872K
BGR icon
2140
BlackRock Energy and Resources Trust
BGR
$410M
$8.14M ﹤0.01%
1,125,549
-18,002
-2% -$129K
KSA icon
2141
iShares MSCI Saudi Arabia ETF
KSA
$626M
$8.13M ﹤0.01%
308,829
+305,206
+8,424% +$7.84M
KEMQ icon
2142
KraneShares Public-Private Emerging Markets Internet and Technology ETF
KEMQ
$25.7M
$8.13M ﹤0.01%
312,531
+127,672
+69% +$2.9M
FNKO icon
2143
Funko
FNKO
$321M
$8.11M ﹤0.01%
1,398,168
+381,144
+37% +$1.85M
SLRC icon
2144
SLR Investment Corp
SLRC
$715M
$8.11M ﹤0.01%
506,563
+166,732
+49% +$2.54M
FCVT icon
2145
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
$8.1M ﹤0.01%
228,327
-12,847
-5% -$420K
IGA
2146
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
$8.1M ﹤0.01%
989,407
+126,738
+15% +$1.02M
ASG
2147
Liberty All-Star Growth Fund
ASG
$338M
$8.09M ﹤0.01%
1,286,797
-5,641
-0.4% -$31.6K
PRAH
2148
DELISTED
PRA Health Sciences, Inc.
PRAH
$8.08M ﹤0.01%
83,061
+1,277
+2% +$119K
DDD icon
2149
3D Systems Corp
DDD
$570M
$8.07M ﹤0.01%
1,154,963
+381,490
+49% +$2.85M
ELF icon
2150
e.l.f. Beauty
ELF
$4.97B
$8.07M ﹤0.01%
423,029
+72,979
+21% +$1.04M

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.